SYMPHONY-1: Phase Ib Results
SYMPHONY-1: Phase Ib Results of Tazemetostat + Lenalidomide and Rituximab in Relapsed/Refractory Follicular Lymphoma

Released: December 17, 2022

Expiration: December 16, 2023

Activity

Progress
1
Course Completed